COVID-19 pandemicVACCINESB African countries face a number of financial and logistical hurdles. b The struggle to get Covid vaccine to the world's population has often been likened to a race - in which case, Af
COVID-19 vaccination development and delivery has been "quite extraordinary," says the World Health Organization's public health physician Margaret Harris, who pointed to the big strides made in understanding the virus in such a short amount of time. The numbers are gr...
A nurse in personal protective equipment (PPE) cares for a patient in a Covid-19 intensive care unit on January 6, 2021, in Los Angeles, California. More than 80% of COVID-19 global deaths during the first two years of the pandemic were among people ag...
Factbox: UK Approves Pfizer-BioNTech COVID-19 Vaccine - Who Gets It First? More Reuters FILE PHOTO: Biontech's logo is seen through a 3D-printed Pfizer logo in this illustration taken November 10, 2020. REUTERS/Dado Ruvic/Illustration LONDON (Reuters) - Britain on Wednes...
population were vaccinated by then. Tedros made the remarks during a visit to a partly state-owned vaccine producer in South Africa on Saturday. He said the World Trade Organization's intellectual property rights agreement on patent waivers was in place for situations like the ...
While doing that we have two key issues: one is prevention and control in communities, meaning we have to cut transmission at the community level," said Liang Wannian, head of COVID-19 response and disposal expert group of China's National Health Commission (NHC). "The second...
The incoming chancellor is likely to continue Austria's current COVID-19 measures, which are among the most restrictive in Europe, including a full lockdown and a pending vaccine mandate. Individual freedom needs to end where the freedom of others begins, Nehammer emphasized. And he pushed f...
GENEVA, May 19 (Xinhua) -- The World Health Organization (WHO) validated on Thursday the CONVIDECIA COVID-19 vaccine developed by Chinese developer CanSino Biologics for emergency use, making it the third Chinese vaccine after Sinopharm and Sinopec having been certified by WHO Emergency Use Listin...
2.1. The use of randomized, placebo control arms in COVID-19 vaccine trials Randomization is a well-established research methodology[12]to deal with therapeutic or prophylactic uncertainty, and to ensure theabsenceof systematic differences between intervention and control groups[13]. Placebos—surrogate...
The International Federation of Pharmaceutical Manufacturers and Associations said Tuesday that about 1.5 billion COVID-19 vaccine doses are now being produced every month, and cited projections that a total of 12 billion will have been produced by year-end. Dr. Bruce Aylward, a top ...